Ju DongYangMD
Gastroenterology • West Hollywood, CABiliary Tract Disease, Gastrointestinal Cancer, Hepatology & Liver Transplantation
Physician
Dr. Yang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8700 Beverly Blvd
West Hollywood, CA 90048Phone+1 310-423-6000Fax+1 310-423-2356
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Transplant Hepatology, 2018 - 2018- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gastroenterology, 2014 - 2017
University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Internal Medicine, 2011 - 2014- Mayo Clinic College of MedicinePost-Doctoral Fellowship, 2009 - 2011
OtherClass of 2005, MD
Certifications & Licensure
CA State Medical License 2018 - 2026
MN State Medical License 2014 - 2019
AR State Medical License 2013 - 2015- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Clinical Trials
- Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study Start of enrollment: 2021 May 11
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 1370 citationsCell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.Katherine A Hoadley, Christina Yau, Toshinori Hinoue, Denise M. Wolf, Alexander J. Lazar
Cell. 2018-04-05 - 2354 citationsA global view of hepatocellular carcinoma: trends, risk, prevention and management.Ju Dong Yang, Pierre Hainaut, Gregory J. Gores, Amina Amadou, Amelie Plymoth
Nature Reviews. Gastroenterology & Hepatology. 2019-08-22 - 213 citationsGenomic, Pathway Network, and Immunologic Features Distinguishing Squamous CarcinomasJoshua D. Campbell, Christina Yau, Reanne Bowlby, Yuexin Liu, Kevin Brennan
Cell Reports. 2018-04-03
Press Mentions
Acceptable Liver Transplant Outcomes Seen After ICI Therapy for Liver CancerAugust 19th, 2024- Acceptable Liver Transplant Outcomes Seen After ICI Therapy for Liver CancerAugust 19th, 2024
- Study: Transplant Possible After Immunotherapy for Advanced Liver Cancer PatientsAugust 8th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
